These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
10. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581 [TBL] [Abstract][Full Text] [Related]
11. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842 [TBL] [Abstract][Full Text] [Related]
12. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791 [TBL] [Abstract][Full Text] [Related]
13. Store-operated calcium entry contributes to abnormal Ca²⁺ signalling in dystrophic mdx mouse myoblasts. Onopiuk M; Brutkowski W; Young C; Krasowska E; Róg J; Ritso M; Wojciechowska S; Arkle S; Zabłocki K; Górecki DC Arch Biochem Biophys; 2015 Mar; 569():1-9. PubMed ID: 25659883 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959 [TBL] [Abstract][Full Text] [Related]
17. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
18. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice. Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SC; Maillet M; Molkentin JD J Biol Chem; 2016 May; 291(19):9920-8. PubMed ID: 26966179 [TBL] [Abstract][Full Text] [Related]
19. Independent variability of microtubule perturbations associated with dystrophinopathy. Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583 [TBL] [Abstract][Full Text] [Related]
20. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]